StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note released on Tuesday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
Shares of CO stock opened at $1.25 on Tuesday. Global Cord Blood has a 12 month low of $2.03 and a 12 month high of $5.50. The stock has a market cap of $151.94 million, a P/E ratio of 1.95 and a beta of 0.16. The company has a 50 day simple moving average of $1.55 and a two-hundred day simple moving average of $1.38.
About Global Cord Blood
Featured Stories
- Five stocks we like better than Global Cord Blood
- How is Compound Interest Calculated?
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Industrial Products Stocks Investing
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Why is the Ex-Dividend Date Significant to Investors?
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.